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Cigarette smoking prevalence in the United States has significantly 
decreased over the past few decades to 15.1% among adults 1 and 9.3% 
among high school students. 2 Declines are a result of a variety of tobacco 
control initiatives, including limits on tobacco marketing, higher per-unit 
cost of tobacco products, clean air legislation, mass media campaigns, and 
reductions in youth access. 3 At the same time, use of electronic nicotine 
delivery systems (ENDS) has rapidly increased. 2 The role of ENDS in 
reducing or exacerbating population-level morbidity and mortality from 
tobacco products remains hotly contested. The increased use of ENDS, 
and the fact that smoking remains the leading cause of preventable death 
in the United States3 indicate that additional policy interventions are 
needed to work toward the tobacco “endgame.” One such intervention is 
raising the minimum legal sales age (MLSA) to 21 years. 4 As more states 
and localities enact Tobacco 21 laws, it is important to consider how such 
policies, initially designed to decrease combustible cigarette and other 
tobacco use, will interact with ENDS use patterns among youth.
How ENDS are incorporated, or not, into state and local tobacco 
regulation, including MLSA laws, has become a key question since 
the issue of the Family Smoking Prevention and Tobacco Control Act 
deeming regulation that defined ENDS as tobacco products. 5 The 
Tobacco Control Act and the deeming rule gave the Food and Drug 
Administration (FDA) comprehensive regulatory authority over the 
manufacture, import, packaging, labeling, advertising, promotion, sale, 
and distribution of all tobacco products. 5 Such regulatory policies include 
the ban of free product samples, required warning labels on packages and 
advertisements, and the prohibition of misleading advertising. 5 Notably, 
state and local governments, not the FDA, retain authority to enact higher 
MLSA legislation.
Given that the majority of daily smokers (85%) begin smoking well 
before age 21, raising the MLSA to 21 years would be an effective 
strategy to prevent youth and young adult initiation of tobacco use, 
largely by reducing the availability of tobacco products to adolescents 
aged 15 to 17 years from their slightly older peers. 4 A report by the 
Institute of Medicine, commissioned on behalf of the FDA, concluded 
that an increase of the MLSA to 21 years would not only aid in reducing 
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initiation of tobacco product use 
among adolescents and young adults, 
but it would also decrease smoking 
prevalence at a population level, and 
thus lead to substantial reductions 
in smoking-related morbidity and 
mortality. 4
Broad public support for higher MLSA 
laws has been reported; according to 
a 2014–2015 national survey, two-
thirds of adults across the United 
States favor increasing the MLSA 
for tobacco products to 21 years. 6 
However, legal and political barriers 
have hindered nationwide adoption 
of Tobacco 21 legislation. First, the 
Tobacco Control Act specifically 
prohibits the FDA from raising the 
MLSA of tobacco products higher 
than the current federal level of 18 
years. 5 This prohibition has led to 
a push toward enactment of higher 
MLSA laws at the state and local 
levels. Hawaii and California have 
successfully enacted Tobacco 21 
policies, and as of August 2016, at 
least 185 localities in 14 states have 
raised the MLSA to 21 years, including 
New York City, Chicago, and Boston. 7 
However, 20 states currently preempt 
local youth access restrictions on 
tobacco that are stricter than state 
law, imposing limitations on local 
authority to raise the MLSA. 8 Although 
repealing preemption is one of the 
goals of most major tobacco control 
advocacy organizations, thus far, 
few states have successfully repealed 
such legislation.9 Second, even with 
strong public support for Tobacco 
21 legislation across the United 
States, political barriers remain due 
to opposition from interest groups, 
such as tobacco manufacturers and 
retailers, that argue higher MLSA laws 
infringe on personal liberty and harm 
small businesses. 10
Tobacco 21 laws that have been 
adopted in Hawaii, California, and 
various localities around the country 
specifically incorporate ENDS 
into those policies, a particularly 
important measure given that past 
30-day ENDS use among youth has
risen dramatically over the past few
years: from 1.5% in 2011 to 16% in
2015 among high school students. 2
Although the risks associated with
ENDS, particularly in the long
term, remain uncertain, there is
no question that nicotine exposure
has harmful effects on the brains
of adolescents and young adults. 3
Areas of the brain involved in higher
cognitive function, particularly
the prefrontal cortex, undergo
substantial development throughout
adolescence and into adulthood 3;
nicotine exposure during this critical
period can result in serious deficits
in cognitive and behavioral function,
including attention deficits and
psychiatric disorders later in life 11 as
well as potential long-term structural
and functional changes in the
brain.12 Furthermore, the developing
adolescent brain is particularly
susceptible to the rewards associated
with nicotine and is more likely
to become addicted; initiation of
smoking earlier in life is associated
with a higher likelihood of becoming
a regular smoker and smoking more
cigarettes as an adult. 13
Tobacco 21 laws that include ENDS 
should reduce initiation of these 
products among youth, similar to the 
suggested impact MLSA laws will have 
on initiation patterns for cigarettes. 4 
Reduced initiation of ENDS through 
MLSA laws may result in reduced 
initiation of cigarettes, and it may also 
result in delayed initiation of cigarette 
use, because the evidence for ENDS 
serving as a gateway to cigarette 
use is increasing. 4,  14 Regardless, it is 
plausible to predict that local, state, 
or federal MLSA laws would have a 
critical role in substantially reducing 
nicotine exposure among adolescents 
and young adults, particularly those 
aged 15 to 17 years.
Although the FDA cannot enact 
higher MLSA regulation to impact 
adolescent ENDS use without 
Congressional action, other actions 
can now be taken by the FDA to 
reduce early initiation of ENDS 
and other tobacco products. 
Priorities could include developing 
more effective ENDS health 
warnings on product packages and 
advertisements, enacting stronger 
restrictions on ENDS advertising and 
marketing, particularly at the point of 
sale, and more effectively regulating 
ENDS sales to minors, including 
internet sales. Although most 
Tobacco 21 legislation thus far has 
incorporated ENDS into policies, it is 
not universal, because some localities 
have exempted ENDS from their 
MLSA increases. It should be possible 
to garner more political support for 
MLSA laws by including, rather than 
excluding, ENDS regulations along 
with traditional tobacco products 
given the strong public support 
for such policies and the fact that 
ENDS use has surpassed the use of 
cigarettes among high schoolers. 2 
Legislative and regulatory actions at 
the state and federal level to address 
increasing the MLSA to 21 years 
for tobacco products, including ENDS, 
will help protect adolescents from 
all tobacco use, nicotine exposure, 
and a potential lifetime of nicotine 
addiction.
ABBREVIATIONS
ENDS:  electronic nicotine 
delivery system
FDA:  Food and Drug 
Administration
MLSA:  minimum legal sales age
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